What is SynNutra?
SynNutra Equine focuses on veterinarian-formulated, all-natural supplements aimed at improving horse health and athletic performance. Their product line is designed to address various equine wellness concerns, including stress management and respiratory health, while strictly adhering to FEI regulations by being free from drugs and prohibited substances. The company emphasizes horse welfare and customer satisfaction, offering a guarantee on its offerings.
How much funding has SynNutra raised?
SynNutra has raised a total of $60K across 1 funding round:
Debt
$60K
Debt (2021): $60K with participation from PPP
What's next for SynNutra?
With the recent influx of substantial expansion capital, SynNutra is poised to scale its operations and potentially broaden its product development or market reach. The company's Series B/C stage funding suggests a strategic phase focused on accelerating growth, enhancing distribution channels, and further solidifying its position as a provider of compliant, drug-free equine wellness solutions. Future developments may include new product formulations or expanded market penetration.
See full SynNutra company page
